Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Go back to Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update| (NASDAQ: DARE) | Delayed: 2.09 +0.04 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.05 | 52 Week High | $ | |||
| Open | $2.02 | 52 Week Low | $ | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $ | |||
| Volume | 56,642 | |||||

